1-Bromopropane; Final Toxic Substances Control Act (TSCA) Risk Evaluation; Notice of Availability, 48687-48689 [2020-17610]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 156 / Wednesday, August 12, 2020 / Notices
Notice is hereby given that the
deadline for filing protests with regard
to the applicant’s request for blanket
authorization, under 18 CFR part 34, of
future issuances of securities and
assumptions of liability, is August 25,
2020.
The Commission encourages
electronic submission of protests and
interventions in lieu of paper, using the
FERC Online links at https://
www.ferc.gov. To facilitate electronic
service, persons with internet access
who will eFile a document and/or be
listed as a contact for an intervenor
must create and validate an
eRegistration account using the
eRegistration link. Select the eFiling
link to log on and submit the
intervention or protests.
Persons unable to file electronically
may mail similar pleadings to the
Federal Energy Regulatory Commission,
888 First Street NE, Washington, DC
20426. Hand delivered submissions in
docketed proceedings should be
delivered to Health and Human
Services, 12225 Wilkins Avenue,
Rockville, Maryland 20852.
In addition to publishing the full text
of this document in the Federal
Register, the Commission provides all
interested persons an opportunity to
view and/or print the contents of this
document via the internet through the
Commission’s Home Page (https://
ferc.gov) using the ‘‘eLibrary’’ link.
Enter the docket number excluding the
last three digits in the docket number
field to access the document. At this
time, the Commission has suspended
access to the Commission’s Public
Reference Room, due to the
proclamation declaring a National
Emergency concerning the Novel
Coronavirus Disease (COVID–19), issued
by the President on March 13, 2020. For
assistance, contact the Federal Energy
Regulatory Commission at
FERCOnlineSupport@ferc.gov or call
toll-free, (886) 208–3676 or TYY, (202)
502–8659.
Dated: August 5, 2020.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2020–17616 Filed 8–11–20; 8:45 am]
BILLING CODE 6717–01–P
VerDate Sep<11>2014
16:37 Aug 11, 2020
Jkt 250001
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPPT–2019–0235; FRL–10013–
37]
1-Bromopropane; Final Toxic
Substances Control Act (TSCA) Risk
Evaluation; Notice of Availability
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Environmental Protection
Agency (EPA) is announcing the
availability of the final Toxic
Substances Control Act (TSCA) risk
evaluation of 1-Bromopropane (1-BP).
The purpose of conducting risk
evaluations under TSCA is to determine
whether a chemical substance presents
an unreasonable risk of injury to health
or the environment under the
conditions of use, including an
unreasonable risk to a relevant
potentially exposed or susceptible
subpopulation, without consideration of
costs or other nonrisk factors. EPA has
determined that specific conditions of
use of 1-BP present an unreasonable risk
of injury to health. For those conditions
of use for which EPA has found an
unreasonable risk, EPA must take
regulatory action to address that
unreasonable risk through risk
management measures enumerated in
TSCA. EPA has also determined that
specific conditions of use do not present
unreasonable risk of injury to health or
the environment. For those conditions
of use for which EPA has found no
unreasonable risk to health or the
environment, the Agency’s
determination is a final Agency action
and is issued via order in the risk
evaluation.
SUMMARY:
The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPPT–2019–0235, is
available online at https://
www.regulations.gov or in-person at the
Office of Pollution Prevention and
Toxics Docket (OPPT Docket),
Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC.
The Public Reading Room is open from
8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The
telephone number for the Public
Reading Room is (202) 566–1744, and
the telephone number for the OPPT
Docket is (202) 566–0280.
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Public Reading
Room is closed to visitors with limited
ADDRESSES:
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
48687
exceptions. The EPA/DC staff continue
to provide remote customer service via
email, phone, and webform. For the
latest status information on EPA/DC
services and docket access, visit https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Dr.
Stan Barone, Office of Pollution
Prevention and Toxics (7403M),
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460–0001; telephone number: (202)
564–1169; email address: barone.stan@
epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public
in general. This action may be of
interest to persons who are or may be
interested in risk evaluations of
chemical substances under TSCA, 15
U.S.C. 2601 et seq. Since other entities
may also be interested in this final risk
evaluation, the EPA has not attempted
to describe all the specific entities that
may be affected by this action.
B. What is EPA’s authority for taking
this action?
TSCA section 6, 15 U.S.C. 2605,
requires EPA to conduct risk
evaluations to ‘‘determine whether a
chemical substance presents an
unreasonable risk of injury to health or
the environment, without consideration
of costs or other nonrisk factors,
including an unreasonable risk to a
potentially exposed or susceptible
subpopulation identified as relevant to
the risk evaluation by the
Administrator, under the conditions of
use.’’ 15 U.S.C. 2605(b)(4)(A). TSCA
sections 6(b)(4)(A) through (H)
enumerate the deadlines and minimum
requirements applicable to this process,
including provisions that provide
instruction on chemical substances that
must undergo evaluation, the minimum
components of a TSCA risk evaluation,
and the timelines for public comment
and completion of the risk evaluation.
TSCA also requires that EPA operate in
a manner that is consistent with the best
available science, make decisions based
on the weight of the scientific evidence
and consider reasonably available
information. 15 U.S.C. 2625(h), (i), and
(k). TSCA section 6(i) directs that a
determination of ‘‘no unreasonable risk’’
E:\FR\FM\12AUN1.SGM
12AUN1
khammond on DSKJM1Z7X2PROD with NOTICES
48688
Federal Register / Vol. 85, No. 156 / Wednesday, August 12, 2020 / Notices
shall be issued by order and considered
to be a final Agency action, while a
determination of ‘‘unreasonable risk’’ is
not considered to be a final Agency
action. 15 U.S.C. 2605(i).
The statute identifies the minimum
components for all chemical substance
risk evaluations. For each risk
evaluation, EPA must publish a
document that outlines the scope of the
risk evaluation to be conducted, which
includes the hazards, exposures,
conditions of use, and the potentially
exposed or susceptible subpopulations
that EPA expects to consider. 15 U.S.C.
2605(b)(4)(D). The statute further
provides that each risk evaluation must
also: (1) Integrate and assess available
information on hazards and exposures
for the conditions of use of the chemical
substance, including information that is
relevant to specific risks of injury to
health or the environment and
information on relevant potentially
exposed or susceptible subpopulations;
(2) describe whether aggregate or
sentinel exposures were considered and
the basis for that consideration; (3) take
into account, where relevant, the likely
duration, intensity, frequency, and
number of exposures under the
conditions of use; and (4) describe the
weight of the scientific evidence for the
identified hazards and exposures. 15
U.S.C. 2605(b)(4)(F)(i)–(ii) and (iv)–(v).
Each risk evaluation must not consider
costs or other nonrisk factors. 15 U.S.C.
2605(b)(4)(F)(iii).
The statute requires that the risk
evaluation process be completed within
a specified timeframe and provide an
opportunity for public comment on a
draft risk evaluation prior to publishing
a final risk evaluation. 15 U.S.C.
2605(b)(4).
Subsection 5.4.1 of the final risk
evaluation for 1-BP constitutes the order
required under TSCA section 6(i)(1),
and the ‘‘no unreasonable risk’’
determinations in that subsection are
considered to be a final Agency action
effective on the date of issuance of the
order. In conducting risk evaluations,
‘‘EPA will determine whether the
chemical substance presents an
unreasonable risk of injury to health or
the environment under each condition
of use within the scope of the risk
evaluation . . .’’ 40 CFR 702.47. Under
EPA’s implementing regulations, ‘‘[a]
determination by EPA that the chemical
substance, under one or more of the
conditions of use within the scope of
the risk evaluation, does not present an
unreasonable risk of injury to health or
the environment will be issued by order
and considered to be a final Agency
action, effective on the date of issuance
of the order.’’ 40 CFR 702.49(d). For
VerDate Sep<11>2014
16:37 Aug 11, 2020
Jkt 250001
purposes of TSCA section 19(a)(1)(A),
the date of issuance of the section 6(i)(1)
order for 1-BP shall be at 1:00 p.m.
Eastern time (standard or daylight, as
appropriate) on the date that is two
weeks after the date when this notice is
published in the Federal Register,
which is in accordance with 40 CFR
23.5.
C. What action is EPA taking?
EPA is announcing the availability of
the risk evaluation of the chemical
substance identified in Unit II. In this
risk evaluation EPA has made
unreasonable risk determinations on
some of the conditions of use within the
scope of the risk evaluation for this
chemical. For those conditions of use
for which EPA has found an
unreasonable risk of injury to health or
the environment, EPA must take
regulatory action to address those risks
through risk management measures
enumerated in 15 U.S.C. 2605(a).
EPA is also announcing the
availability of the information required
to be provided publicly with each risk
evaluation, which is available online at
https://www.regulations.gov in the
dockets identified. 40 CFR 702.51.
Specifically, EPA has provided:
• The scope document and problem
formulation (in Docket ID No. EPA–HQ–
OPPT–2016–0741);
• Draft risk evaluation, and final risk
evaluation (in Docket ID No. EPA–HQ–
OPPT–2019–0235);
• All notices, determinations,
findings, consent agreements, and
orders (in Docket ID No. EPA–HQ–
OPPT–2019–0235);
• Any information required to be
provided to the Agency under 15 U.S.C.
2603 (in Docket ID No. EPA–HQ–OPPT–
2016–0741 and Docket ID No. EPA–HQ–
OPPT–2019–0235);
• A nontechnical summary of the risk
evaluation (in Docket ID No. EPA–HQ–
OPPT–2019–0235);
• A list of the studies, with the results
of the studies, considered in carrying
out each risk evaluation (Risk
Evaluation for 1-Bromopropane in
Docket ID No. EPA–HQ–OPPT–2019–
0235);
• The final peer review report,
including the response to peer review
and public comments received during
peer review (in Docket ID No. EPA–HQ–
OPPT–2019–0235); and
• Response to public comments
received on the draft scope and the draft
risk evaluation (in Docket ID No. EPA–
HQ–OPPT–2019–0235).
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
II. TSCA Risk Evaluation
A. What is EPA’s risk evaluation process
for existing chemicals under TSCA?
The risk evaluation process is the
second step in EPA’s existing chemical
process under TSCA, following
prioritization and before risk
management. As this chemical is one of
the first ten chemical substances
undergoing risk evaluation, the
chemical substance was not required to
go through prioritization (81 FR 91927,
December 19, 2016) (FRL–9956–47). The
purpose of conducting risk evaluations
is to determine whether a chemical
substance presents an unreasonable risk
of injury to health or the environment
under the conditions of use, including
an unreasonable risk to a relevant
potentially exposed or susceptible
subpopulation. As part of this process,
EPA must evaluate both hazard and
exposure, not consider costs or other
nonrisk factors, use reasonably available
information and approaches in a
manner that is consistent with the
requirements in TSCA for the use of the
best available science, and ensure
decisions are based on the weight of
scientific evidence.
The specific risk evaluation process
that EPA has established by rule to
implement the statutory process is set
out in 40 CFR part 702 and summarized
on EPA’s website at https://
www.epa.gov/assessing-and-managingchemicals-under-tsca/risk-evaluationsexisting-chemicals-under-tsca. As
explained in the preamble to EPA’s final
rule on procedures for risk evaluation
(82 FR 33726, July 20, 2017) (FRL–
9964–38), the specific regulatory
process set out in 40 CFR part 702,
subpart B is being followed for the first
ten chemical substances undergoing risk
evaluation to the maximum extent
practicable.
Prior to the publication of this final
risk evaluation, a draft risk evaluation
was subject to peer review and public
comment. EPA reviewed the report from
the peer review committee and public
comments and has amended the risk
evaluation in response to these
comments as appropriate. The public
comments, peer review report, and
EPA’s response to comments is in
Docket ID No. EPA–HQ–OPPT–2019–
0235. Prior to the publication of the
draft risk evaluation, EPA made
available the scope and problem
formulation, and solicited public input
on uses and exposure. EPA’s documents
and the public comments are in Docket
ID No. EPA–HQ–OPPT–2016–0741.
Additionally, information about the
scope, problem formulation, and draft
risk evaluation phases of the TSCA risk
E:\FR\FM\12AUN1.SGM
12AUN1
Federal Register / Vol. 85, No. 156 / Wednesday, August 12, 2020 / Notices
evaluation for this chemical is at https://
www.epa.gov/assessing-and-managingchemicals-under-tsca/risk-evaluation-1bromopropane-1-bp.
B. What is 1-Bromopropane?
1-BP, also known as n-propyl
bromide, is a volatile chemical used as
a solvent for cleaning and degreasing
(including vapor degreasing, cold
cleaning, and aerosol degreasing). Other
uses for 1-BP are for consumer and
commercial products as adhesives and
sealants, in furniture care products, in
dry cleaning, spot cleaning and other
Authority: 15 U.S.C. 2601 et seq.
Andrew Wheeler,
Administrator.
[FR Doc. 2020–17610 Filed 8–11–20; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL COMMUNICATIONS
COMMISSION
[FRS 16990]
Deletion of Items From August 6, 2020
Open Meeting
August 5, 2020.
The following items have been
adopted by the Commission and deleted
from the list of items scheduled for
consideration at the Thursday, August
6, 2020, Open Meeting. The items were
previously listed in the Commission’s
Notice of Thursday, July 30, 2020.
Item No.
Bureau
Subject
3 ......................
MEDIA ......................................................
4 ......................
CONSUMER & GOVERNMENTAL AFFAIRS.
Title: Common Antenna Siting Rules (MB Docket No. 19–282); Modernization of
Media Regulation Initiative (MB Docket No. 17–105).
Summary: The Commission will consider a Report and Order that would eliminate
the common antenna siting rules for FM and TV broadcaster applicants and licensees.
Title: Telecommunications Relay Service (CG Docket No. 03–123).
Summary: The Commission will consider a Report and Order to repeal certain
TRS rules that are no longer needed in light of changes in technology and voice
communications services.
Federal Communications Commission.
Marlene Dortch,
Secretary.
[FR Doc. 2020–17565 Filed 8–11–20; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL MARITIME COMMISSION
[Docket No. 20–12]
Nnabugwu Chinedu Andrew, Avers
Logistics Ltd., and CJ Deluz Nigeria
Ltd., Complainants v. Marine Transport
Logistics, Inc., Alla Solovyeva, and
Raya Bakhirev, Respondents; Filing of
Complaint and Assignment
Served: August 6, 2020.
khammond on DSKJM1Z7X2PROD with NOTICES
liquid, spray, and aerosol cleaners, and
in automotive care products.
Information from the 2016 Chemical
Data Reporting (CDR) for 1-BP indicates
the reported production volume is
between 10 million and 26 million lbs/
year (manufacture and import).
48689
Notice is given that a complaint has
been filed with the Federal Maritime
Commission (Commission) by
Nnabugwu Chinedu Andrew, Avers
Logistics Ltd., and CJ Deluz Nigeria Ltd.,
hereinafter ‘‘Complainants’’, against
Marine Transport Logistics, Inc., Alla
Solovyeva, and Raya Bakhirev,
hereinafter ‘‘Respondents’’.
Complainants state they ‘‘are and were
foreign buyers of automobiles and were
located in the State of Lagos, Federal
Republic of Nigeria.’’ Complainant
states that Respondent Marine Transport
Logistics, Inc. ‘‘is and was an
international shipping company,
providing freight forwarding and
logistics services to customers on a
worldwide basis and is principally
located in the New York City area.’’
Complainants state that Respondent
VerDate Sep<11>2014
16:37 Aug 11, 2020
Jkt 250001
Alla Solovyeva ‘‘is and was an officer of
MTL.’’ Complainants state that
Respondent Raya Bakhirev ‘‘is and was
employed by MTL as a General
Manager.’’
Complainant alleges they hired
Respondent Marine Transport Logistics,
Inc. ‘‘to ship Complainants’ vehicles
described herein from a warehouse
operated by MTL in the United States to
various locations abroad via ocean going
vessel.’’
Complainant alleges that Respondents
violated 46 U.S.C. 41102(b), 41102(c),
40102(6)(A)(ii), 40901(a), and 41104.
Complainant seeks $172,852.00 in
reparations and other relief.
The full text of the complaint can be
found in the Commission’s Electronic
Reading Room at https://www2.fmc.gov/
readingroom/proceeding/20-12/.
This proceeding has been assigned to
Office of Administrative Law Judges.
The initial decision of the presiding
office in this proceeding shall be issued
by August 6, 2021, and the final
decision of the Commission shall be
issued by February 23, 2022.
Rachel Dickon,
Secretary.
[FR Doc. 2020–17655 Filed 8–11–20; 8:45 am]
BILLING CODE 6730–02–P
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue, NW,
Washington DC 20551–0001, not later
than August 27, 2020.
E:\FR\FM\12AUN1.SGM
12AUN1
]]>Agencies
[Federal Register Volume 85, Number 156 (Wednesday, August 12, 2020)]
[Notices]
[Pages 48687-48689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17610]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2019-0235; FRL-10013-37]
1-Bromopropane; Final Toxic Substances Control Act (TSCA) Risk
Evaluation; Notice of Availability
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Environmental Protection Agency (EPA) is announcing the
availability of the final Toxic Substances Control Act (TSCA) risk
evaluation of 1-Bromopropane (1-BP). The purpose of conducting risk
evaluations under TSCA is to determine whether a chemical substance
presents an unreasonable risk of injury to health or the environment
under the conditions of use, including an unreasonable risk to a
relevant potentially exposed or susceptible subpopulation, without
consideration of costs or other nonrisk factors. EPA has determined
that specific conditions of use of 1-BP present an unreasonable risk of
injury to health. For those conditions of use for which EPA has found
an unreasonable risk, EPA must take regulatory action to address that
unreasonable risk through risk management measures enumerated in TSCA.
EPA has also determined that specific conditions of use do not present
unreasonable risk of injury to health or the environment. For those
conditions of use for which EPA has found no unreasonable risk to
health or the environment, the Agency's determination is a final Agency
action and is issued via order in the risk evaluation.
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPPT-2019-0235, is available online
at https://www.regulations.gov or in-person at the Office of Pollution
Prevention and Toxics Docket (OPPT Docket), Environmental Protection
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg.,
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading
Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday,
excluding legal holidays. The telephone number for the Public Reading
Room is (202) 566-1744, and the telephone number for the OPPT Docket is
(202) 566-0280.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Public Reading Room is closed to visitors
with limited exceptions. The EPA/DC staff continue to provide remote
customer service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Dr. Stan Barone, Office of
Pollution Prevention and Toxics (7403M), Environmental Protection
Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone
number: (202) 564-1169; email address: [email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general. This action may
be of interest to persons who are or may be interested in risk
evaluations of chemical substances under TSCA, 15 U.S.C. 2601 et seq.
Since other entities may also be interested in this final risk
evaluation, the EPA has not attempted to describe all the specific
entities that may be affected by this action.
B. What is EPA's authority for taking this action?
TSCA section 6, 15 U.S.C. 2605, requires EPA to conduct risk
evaluations to ``determine whether a chemical substance presents an
unreasonable risk of injury to health or the environment, without
consideration of costs or other nonrisk factors, including an
unreasonable risk to a potentially exposed or susceptible subpopulation
identified as relevant to the risk evaluation by the Administrator,
under the conditions of use.'' 15 U.S.C. 2605(b)(4)(A). TSCA sections
6(b)(4)(A) through (H) enumerate the deadlines and minimum requirements
applicable to this process, including provisions that provide
instruction on chemical substances that must undergo evaluation, the
minimum components of a TSCA risk evaluation, and the timelines for
public comment and completion of the risk evaluation. TSCA also
requires that EPA operate in a manner that is consistent with the best
available science, make decisions based on the weight of the scientific
evidence and consider reasonably available information. 15 U.S.C.
2625(h), (i), and (k). TSCA section 6(i) directs that a determination
of ``no unreasonable risk''
[[Page 48688]]
shall be issued by order and considered to be a final Agency action,
while a determination of ``unreasonable risk'' is not considered to be
a final Agency action. 15 U.S.C. 2605(i).
The statute identifies the minimum components for all chemical
substance risk evaluations. For each risk evaluation, EPA must publish
a document that outlines the scope of the risk evaluation to be
conducted, which includes the hazards, exposures, conditions of use,
and the potentially exposed or susceptible subpopulations that EPA
expects to consider. 15 U.S.C. 2605(b)(4)(D). The statute further
provides that each risk evaluation must also: (1) Integrate and assess
available information on hazards and exposures for the conditions of
use of the chemical substance, including information that is relevant
to specific risks of injury to health or the environment and
information on relevant potentially exposed or susceptible
subpopulations; (2) describe whether aggregate or sentinel exposures
were considered and the basis for that consideration; (3) take into
account, where relevant, the likely duration, intensity, frequency, and
number of exposures under the conditions of use; and (4) describe the
weight of the scientific evidence for the identified hazards and
exposures. 15 U.S.C. 2605(b)(4)(F)(i)-(ii) and (iv)-(v). Each risk
evaluation must not consider costs or other nonrisk factors. 15 U.S.C.
2605(b)(4)(F)(iii).
The statute requires that the risk evaluation process be completed
within a specified timeframe and provide an opportunity for public
comment on a draft risk evaluation prior to publishing a final risk
evaluation. 15 U.S.C. 2605(b)(4).
Subsection 5.4.1 of the final risk evaluation for 1-BP constitutes
the order required under TSCA section 6(i)(1), and the ``no
unreasonable risk'' determinations in that subsection are considered to
be a final Agency action effective on the date of issuance of the
order. In conducting risk evaluations, ``EPA will determine whether the
chemical substance presents an unreasonable risk of injury to health or
the environment under each condition of use within the scope of the
risk evaluation . . .'' 40 CFR 702.47. Under EPA's implementing
regulations, ``[a] determination by EPA that the chemical substance,
under one or more of the conditions of use within the scope of the risk
evaluation, does not present an unreasonable risk of injury to health
or the environment will be issued by order and considered to be a final
Agency action, effective on the date of issuance of the order.'' 40 CFR
702.49(d). For purposes of TSCA section 19(a)(1)(A), the date of
issuance of the section 6(i)(1) order for 1-BP shall be at 1:00 p.m.
Eastern time (standard or daylight, as appropriate) on the date that is
two weeks after the date when this notice is published in the Federal
Register, which is in accordance with 40 CFR 23.5.
C. What action is EPA taking?
EPA is announcing the availability of the risk evaluation of the
chemical substance identified in Unit II. In this risk evaluation EPA
has made unreasonable risk determinations on some of the conditions of
use within the scope of the risk evaluation for this chemical. For
those conditions of use for which EPA has found an unreasonable risk of
injury to health or the environment, EPA must take regulatory action to
address those risks through risk management measures enumerated in 15
U.S.C. 2605(a).
EPA is also announcing the availability of the information required
to be provided publicly with each risk evaluation, which is available
online at https://www.regulations.gov in the dockets identified. 40 CFR
702.51. Specifically, EPA has provided:
The scope document and problem formulation (in Docket ID
No. EPA-HQ-OPPT-2016-0741);
Draft risk evaluation, and final risk evaluation (in
Docket ID No. EPA-HQ-OPPT-2019-0235);
All notices, determinations, findings, consent agreements,
and orders (in Docket ID No. EPA-HQ-OPPT-2019-0235);
Any information required to be provided to the Agency
under 15 U.S.C. 2603 (in Docket ID No. EPA-HQ-OPPT-2016-0741 and Docket
ID No. EPA-HQ-OPPT-2019-0235);
A nontechnical summary of the risk evaluation (in Docket
ID No. EPA-HQ-OPPT-2019-0235);
A list of the studies, with the results of the studies,
considered in carrying out each risk evaluation (Risk Evaluation for 1-
Bromopropane in Docket ID No. EPA-HQ-OPPT-2019-0235);
The final peer review report, including the response to
peer review and public comments received during peer review (in Docket
ID No. EPA-HQ-OPPT-2019-0235); and
Response to public comments received on the draft scope
and the draft risk evaluation (in Docket ID No. EPA-HQ-OPPT-2019-0235).
II. TSCA Risk Evaluation
A. What is EPA's risk evaluation process for existing chemicals under
TSCA?
The risk evaluation process is the second step in EPA's existing
chemical process under TSCA, following prioritization and before risk
management. As this chemical is one of the first ten chemical
substances undergoing risk evaluation, the chemical substance was not
required to go through prioritization (81 FR 91927, December 19, 2016)
(FRL-9956-47). The purpose of conducting risk evaluations is to
determine whether a chemical substance presents an unreasonable risk of
injury to health or the environment under the conditions of use,
including an unreasonable risk to a relevant potentially exposed or
susceptible subpopulation. As part of this process, EPA must evaluate
both hazard and exposure, not consider costs or other nonrisk factors,
use reasonably available information and approaches in a manner that is
consistent with the requirements in TSCA for the use of the best
available science, and ensure decisions are based on the weight of
scientific evidence.
The specific risk evaluation process that EPA has established by
rule to implement the statutory process is set out in 40 CFR part 702
and summarized on EPA's website at https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-evaluations-existing-chemicals-under-tsca. As explained in the preamble to EPA's final rule on
procedures for risk evaluation (82 FR 33726, July 20, 2017) (FRL-9964-
38), the specific regulatory process set out in 40 CFR part 702,
subpart B is being followed for the first ten chemical substances
undergoing risk evaluation to the maximum extent practicable.
Prior to the publication of this final risk evaluation, a draft
risk evaluation was subject to peer review and public comment. EPA
reviewed the report from the peer review committee and public comments
and has amended the risk evaluation in response to these comments as
appropriate. The public comments, peer review report, and EPA's
response to comments is in Docket ID No. EPA-HQ-OPPT-2019-0235. Prior
to the publication of the draft risk evaluation, EPA made available the
scope and problem formulation, and solicited public input on uses and
exposure. EPA's documents and the public comments are in Docket ID No.
EPA-HQ-OPPT-2016-0741. Additionally, information about the scope,
problem formulation, and draft risk evaluation phases of the TSCA risk
[[Page 48689]]
evaluation for this chemical is at https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-evaluation-1-bromopropane-1-bp.
B. What is 1-Bromopropane?
1-BP, also known as n-propyl bromide, is a volatile chemical used
as a solvent for cleaning and degreasing (including vapor degreasing,
cold cleaning, and aerosol degreasing). Other uses for 1-BP are for
consumer and commercial products as adhesives and sealants, in
furniture care products, in dry cleaning, spot cleaning and other
liquid, spray, and aerosol cleaners, and in automotive care products.
Information from the 2016 Chemical Data Reporting (CDR) for 1-BP
indicates the reported production volume is between 10 million and 26
million lbs/year (manufacture and import).
Authority: 15 U.S.C. 2601 et seq.
Andrew Wheeler,
Administrator.
[FR Doc. 2020-17610 Filed 8-11-20; 8:45 am]
BILLING CODE 6560-50-P
